Increased iron levels of the substantia nigra and the discovery of ceruloplasmin mutations in patients with Parkinson's disease (PD) imply impaired iron metabolism in this neurodegenerative disorder. Ceruloplasmin has ferroxidase activity oxidizing iron(II) to iron(III). In the present study, we analyzed the amount of ceruloplasmin, iron, ferritin, and transferrin and the ceruloplasmin ferroxidase activity in serum of patients with the diagnosis of PD carrying the ceruloplasmin mutations I63T, D544E, and R793H. The impact of these missense mutations on the biosynthesis of holo-ceruloplasmin was investigated in cell culture experiments. Functional relevance was found for the ceruloplasmin mutations I63T and D544E. In vivo, the I63T mutation resulted in half the normal ceruloplasmin concentration and markedly reduced ferroxidase activity in serum from a heteroallelic PD patient. In cell culture, the I63T glycosylphosphatidylinositol (GPI)-linked ceruloplasmin isoform was retained in the endoplasmatic reticulum of human embryonic kidney cells. Furthermore, the D544E polymorphism resulted in significantly reduced serum ceruloplasmin levels and ferroxidase activity in heteroallelic patients and in expression of mainly apo-ceruloplasmin in cell culture. Our studies indicate that altered activity of ceruloplasmin may present a vulnerability factor for iron induced oxidative stress in PD.
Iron is an essential trace element. However, its potential to generate highly toxic hydroxyl radicals by oxidation of iron(II) to iron(III) and decomposition of H 2 O 2 via the Fenton reaction requires a tightly regulated iron metabolism. Thus, iron increase as observed in PD favors the oxidative stress hypothesis. This hypothesis is further substantiated by iron-loaded animal models (11) (12) (13) (14) (15) .
The discovery of neurodegenerative disorders associated with brain iron accumulation and mutations in genes encoding proteins of iron metabolism have reinforced the hypothesis of impaired brain iron metabolism in PD [reviewed in (16) (17) (18) (19) ]. Ceruloplasmin, one of these proteins, is an abundant glycoprotein with a molecular mass of ~132 kDa. This multicopper oxidase contains six copper atoms incorporated during the ceruloplasmin biosynthesis. Although ceruloplasmin oxidizes multiple substrates, its role as a ferroxidase in iron metabolism seems to be the main function of ceruloplasmin within the brain in vivo. Ceruloplasmin oxidizes iron(II) to iron(III) without releasing radical oxygen species. Ceruloplasmin synthesis occurs mainly in hepatocytes, followed by secretion to the plasma (20) . However, extrahepatic expression has also been reported (21) (22) (23) (24) . In the mammalian brain, the main ceruloplasmin isoform is generated by alternative splicing in astrocytes and is anchored to the membrane of these cells via a glycosylphosphatidylinositol (GPI) anchor (25) . Localization of these astrocytes to the microvasculature surrounding, e.g., dopaminergic neurons of the SN (26) stresses the importance of GPI-ceruloplasmin for iron uptake into the central nervous system (CNS) across the blood brain barrier (27) . Additionally, GPI-ceruloplasmin is involved in iron export from astrocytes (28) .
The role of ceruloplasmin in brain iron metabolism has been verified by loss of function mutations in the ceruloplasmin gene in hereditary aceruloplasminemia and by ceruloplasmin (−/−) deficient mice displaying brain iron accumulation (29, 30) . Here, iron-induced oxidative injury was evidenced by increased lipid peroxidation (30, 31) and by mitochondrial dysfunction of the basal ganglia (31) .
Parkinsonism present in some cases of aceruloplasminemia (32) implies that sequence variations in ceruloplasmin might cause iron-induced oxidative stress that could lead to or at least contribute to neurodegeneration in PD. A possible involvement of ceruloplasmin in the pathogenesis of PD is further supported by immunohistochemical studies that reveal a colocalization of ceruloplasmin and Lewy bodies (33) , the pathological hallmark of PD. Indeed, by screening the ceruloplasmin gene in a cohort of PD patients in comparison to matched controls we identified three missense-mutations and found the I63T associated with PD, the R793H substitution with increased hyperechogenicity of the SN and the D544E to be associated with both (33) .
In the current study, we investigated the functional impact of these three ceruloplasmin missense mutations on holo-ceruloplasmin biosynthesis and ferroxidase activity.
MATERIALS AND METHODS

Collection of serum samples
Serum samples were obtained from a German cohort of PD patients and ethnically matched controls. Both groups were previously analyzed for mutations in the ceruloplasmin gene and assessed by transcranial ultrasound for SN echogenicity, a marker for SN iron content (33) . Selection criteria for patients and controls were the existence of at least one of the following ceruloplasmin mutations: I63T, D544E, and R793H. These ceruloplasmin mutations, all found to be heterozygous in patients and controls, were more frequent in patients. However, only a subgroup of the individuals affected by the three missense mutations agreed to participate in further functional studies. All PD patients with at least one of these mutations, except of one patient harboring the D544E polymorphism, showed an increased area of hyperechogenicity on at least one side of the SN (33) . Healthy individuals without these mutations and with normal echogenicity of the SN, indicating that there was no evidence for increased SN iron content, were selected as controls. All individuals, summarized in Table 1 , agreed to participate in this study and gave informed consent according to the declaration of Helsinki. Levels of serum ceruloplasmin, iron, ferritin, and transferrin were determined for all individuals by standardized methods. Transferrin saturation was calculated with the following formula: [serum iron (µg/dl)/ serum transferrin (mg/dl)] × 71.
Ferroxidase assay
Ferroxidase activity of serum-ceruloplasmin was measured by quantifying the remaining Fe 2+ in the reaction solution after a set point of time and addition of a defined amount of Fe 2+ as described elsewhere (34) . The Fe 2+ concentration was read from a calibration curve generated with EDTA dilutions of 8.9-0.0 mM EDTA. One unit was defined as the amount of ceruloplasmin that oxidized 1 µmol of Fe 2+ per min. The ferroxidase activity for each individual was determined in at least three independent assays.
Flag tagging of GPI-linked isoforms of ceruloplasmin
The full-length cDNA of human GPI-linked ceruloplasmin, encoding the precursor protein with a N-terminal 19-amino acid signal peptide and cloned into the pcDNA3.0 plasmid, was kindly provided by Professor J. D. Gitlin (Washington University, St. Louis, MO) and characterized elsewhere (35) . To incorporate a Flag-tag downstream of the GPI-ceruloplasmin signal peptide encoding sequence, polymerase chain reaction (PCR) was performed. A Flag (underlined) encoding forward primer with an added AflII restriction site (bold italic) and flanking regions homologous to the sequence of GPI-ceruloplasmin/ 5′GGAGACCCAAGCTTGGATCCATGAAGATTTTGATACTTGGTATTTTTCTGTTTT TATGTAGTACCCCAGCCTGGGCGCTTAAGGATTACAAGGATGACGACGATAAGA AAGAAAAGCATTATTAC 3′ and the reverse primer homologous to nucleotides 258-286 of GPI-ceruloplasmin/5′TAGGGCCTAAAAACCCAAGC 3′ were used. This PCR product was digested with HindIII and AgeI and subcloned into the full-length cDNA clone of GPI-ceruloplasmin generating a Flag-tagged expression construct (pcDNA3_Flag-GPI-Cp). The sequence of the construct was verified by automated dye-terminator cycle sequencing (Beckman Coulter GmbH, Krefeld, Germany) according to the manufacturer's recommendations. Enzymes were from New England Biolabs GmbH (Frankfurt am Main, Germany).
Site-directed mutagenesis of GPI-linked ceruloplasmin
Single nucleotide exchanges in GPI-ceruloplasmin representing I63T, D544E, and R793H missense mutations were introduced by the QuikChange site-directed mutagenesis technique (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The indicated primers were used, and the modified nucleotides in the sequence are underlined: forward primers Fwd-I63T/ 5′CAAAATGGCCCAGATAGAACTGGGAGACTATATAAGAAG 3′, Fwd-D544E/ 5′TAAGATGTATTATTCTGCTGTGGAACCCACTAAAGATATATTCACTG 3′, Fwd-R793H/ 5′GTATACTGATAGCACATTCCATGTTCCAGTGGAGAGAAA 3′; and reverse primers Rev-I63T/ 5′CTTCTTATATAGTCTCCCAGTTCTATCTGGGCCATTTTG 3′, Rev-D544E/ 5′CAGTGAATATATCTTTAGTGGGTTCCACAGCAGAATAATACATCTTA 3′, Rev-R793H/ 5′TTTCTCTCCACTGGAACATGGAATGTGCTATCAGTATAC 3′. All mutations were confirmed by DNA sequence analysis of the entire cDNA sequence.
Cell transfection and immunofluorescence staining
Human embryonic kidney (HEK293) cells were cultured in a 5% CO 2 atmosphere at 37°C in Dulbecco's modified Eagle's medium (GIBCO ® , Invitrogen GmbH, Karlsruhe, Germany) supplemented with 10% (v/v) fetal calf serum, penicillin (100 U/ml), streptomycin (100 µg/ml), and amphotericin B (250 ng/ml). Transient transfections of HEK293 cells were performed with Effectene ® Transfection Reagent (QIAGEN GmbH, Hilden, Germany) according to the manufacturer's instructions. For indirect immunofluorescence, transfected HEK293 cells were plated onto poly-L-lysine-coated glass coverslips. At 48-72 h after transfection, cells were washed with phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde, pH 7.4, for 15 min at room temperature, and permeabilized in 100% methanol for 8 min at -20°C. Permeabilized cells were washed, blocked with 5% normal donkey serum (NDS) for 1 h at room temperature and stained with either anti-Flag (1:1000, Sigma-Aldrich Chemie GmbH, Munich, Germany) or anti-ceruloplasmin (1:20000, DakoCytomation GmbH, Hamburg, Germany) polyclonal rabbit antibodies and anti-protein disulfide isomerase (1:800, Stressgen Biotechnologies Inc., San Diego, CA) mouse monoclonal antibodies for 1 h at 37°C. After washing, cells were further incubated at room temperature with Cy2-conjugated donkey anti-rabbit IgG (1:1000, Dianova GmbH, Hamburg, Germany) and Cy3-conjugated donkey anti-mouse IgG (1:500, Dianova GmbH, Hamburg, Germany). All primary and secondary antibodies were diluted in PBS containing 3% NDS. After 1 h, cells were washed in PBS and mounted in fluorescencepreserving medium (ProLong ® Antifade kit, Molecular Probes™, Invitrogen GmbH, Karlsruhe, Germany). Fluorescence staining was visualized using a LSM 510 META laser-scanning microscope (Carl Zeiss AG, Goettingen, Germany), and sectioned images of cells were generated. Images were stored and processed using LSM image browser (Carl Zeiss AG, Goettingen, Germany).
Western-blot analysis, immunoprecipitation and endoglycosidase H digest
Cells were washed with PBS 48-72 h after transfection and lysed by incubation in lysis buffer (50 mM Tris-HCl, 1% Nonidet P-40, 2 mM EDTA, 100 mM NaCl, pH 7,5) containing a mixture of protease inhibitors (Complete, Roche Diagnostics GmbH, Mannheim, Germany). The protein concentration of the precleared cell lysate was determined with the Bio-Rad Protein Assay (BioRad Laboratories GmbH, Munich, Germany). In some experiments, precleared cell lysates were immunoprecipitated with anti-Flag ® M2 Affinity Gel (Sigma-Aldrich Chemie GmbH, Munich, Germany) and centrifuged for 1 min at 16100 × g at 4°C. The supernatant was removed, and the resin was washed three times with ice-cold lysis buffer and once with ice-cold PBS. The immunoprecipitate was eluted by boiling in the presence of 4.3 mM Tris-HCl, pH 8.0, containing 1.7% SDS for 5 min and centrifugation for 15 min at 16100 × g at 4°C. The supernatant was split into two aliquots and incubated for 16 h at 37°C in the presence or absence of 0.1 mU/µl endoglycosidase H (Roche Diagnostics GmbH, Mannheim, Germany) in 50 mM sodium acetate buffer, pH 5.7, containing a mixture of protease inhibitors (35) . Immunoprecipitates or 30 µg of precleared cell lysate proteins were subjected to 7.5% SDS-PAGE under denaturing and reducing conditions and transferred to a polyvinylidene difluoride membrane (Millipore GmbH, Schwalbach, Germany). To detect holo-GPI-ceruloplasmin, cell lysates were electrophoresed under nonreducing conditions without heat denaturation before loading. Membranes were blocked with 4% skim milk powder in Tris-buffered saline containing 0,1% Tween-20 (TBST) overnight at 4°C. Then, membranes were incubated with primary antibodies, polyclonal rabbit anti-Flag (1:3000), anti-ceruloplasmin antibodies (1:200000), or mouse anti-Tubulin monoclonal antibody (1:200000, Oncogene Research Products, San Diego, CA), for 2.5 h at room temperature. After being washed four times with TBST, membranes were incubated with secondary antibodies, HRP-conjugated anti-rabbit IgG (1:3000), or anti-mouse IgG (1:2500, Amersham Biosciences Europe GmbH, Freiburg, Germany). All antibodies were diluted in TBST. Membranes were washed as before and developed using an ECL kit (Amersham Biosciences Europe GmbH, Freiburg, Germany). For reprobing, membranes were incubated with stripping buffer (25 mM glycine, 1% SDS, pH 2) for 20 min at room temperature, washed three times with TBST, and detected with primary and secondary antibodies as described before.
Statistical analysis for the D544E polymorphism
Only for the carriers of the D554E polymorphism, statistical analyses were applicable. Data were inspected graphically to seize on potential outliers using the 2.5σ-criterion. 98% of all ceruloplasmin values were below 62.3 mg/dl but one dataset (control) was excluded from statistical analyzes because of its extreme ceruloplasmin serum concentration (107.0 mg/dl). As ceruloplasmin is also known to be expressed differently in inflammatory reactions, a likely explanation for this extreme value would be an up-regulation of ceruloplasmin in an inflammatory process. All variables, ceruloplasmin, iron, ferritin and transferrin concentration, transferrin saturation, and ferroxidase activity, were first analyzed for normal distribution of data within groups (Shapiro-Wilk test) and homogeneity of variance among groups (Folded Form F statistic). Transforming ceruloplasmin and ferritin data, respectively, with the natural logarithm, no significant deviation from normality could be observed for any variable. Homogeneity of variance among the groups of probands was found for all variables with exception of ceruloplasmin. To determine differences between groups, two approximate t tests were performed with an adjustment for unequal variance (36) . For each group, linear regression analysis was performed to check for correlations between the variables within each group. In the case of multiple testing a sequential Bonferroni procedure was used in order to compensate for an inflating type 1 error (37). The extremest significance level was set to α = 0.008 (α=0.05; n=6; α =0.05/6).
RESULTS
Serum analysis
The impact of three ceruloplasmin missense-mutations (I63T, D544E, and R793H) on the systemic iron metabolism in PD was studied. Mean serum concentrations of ceruloplasmin, iron, ferritin and transferrin, the ceruloplasmin ferroxidase activity, and the transferrin saturation for PD patients and controls are given in Table 2 .
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The ceruloplasmin concentration in the only carrier of the I63T substitution, a male PD patient, was half of the concentration measured in the control group [14. PD patients with the D544E substitution compared with controls unaffected by this missense mutation revealed a significant decrease in serum ceruloplasmin concentration and ferroxidase activity (t test, P=0.003 and P<0.001), respectively. When comparing controls with the D544E polymorphism to controls without this polymorphism no significant association between any serum variable and the D544E substitution was detected. However, great variation ranges of two variables, ceruloplasmin and ferroxidase activity, were observed in the control group carrying the D544E exchange. Linear regression analysis in PD patients and controls carrying the D544E ceruloplasmin polymorphism and normal controls without this polymorphism revealed a significant positive correlation for iron and transferrin saturation in all three groups (r=0.931, r=0.850, r=0.956, respectively; P≤0.008). However, only in normal controls significant correlations between ferroxidase activity and iron (r=-0.608, P=0.002), ceruloplasmin (r=0.599, P=0.003), and transferrin saturation (r=-0.561, P=0.005) were observed indicating that only this group displayed normal ceruloplasmin ferroxidase activity (Fig. 1 ).
In the two male PD patients with the R793H substitution a reduction by 16-19% 
Ceruloplasmin biosynthesis
As we and others (38) did not detect endogenous ceruloplasmin expression in untransfected HEK293 cells by immunofluorescencence and Western blot analysis, we used these cells to study the expression and intracellular localization of wild-type GPI-ceruloplasmin and its mutated isoforms. HEK293 cells were transfected with cDNAs encoding human GPI-linked and Flag-tagged wild-type ceruloplasmin, I63T-ceruloplasmin, D544E-ceruloplasmin, or R793H-ceruloplasmin followed by indirect immunofluorescence staining for intracellular localization ( Fig. 2A) . Consistent with previous observations, confocal microsopy revealed cell surface staining for wild-type GPI-ceruloplasmin (35) . This staining pattern was also displayed for the two mutated GPI-isoforms D544E and R793H, respectively. In contrast, the I63T mutated GPIceruloplasmin was found to co-localize with the endoplasmatic reticulum (ER) resident protein disulfide isomerase.
Western blot analysis of transfected HEK293 cells, lysed at different time points following transfection, revealed for the GPI-ceruloplasmin isoforms of wild-type, D544E, and R793H the gradual appearance of a second higher molecular weight band, simultaneously to the disappearance of the lower molecular weight band (Fig. 2B) . For I63T GPI-ceruloplasmin, however, a distinct band pattern was observed, mainly displaying the low-molecular-weight band (Fig. 2B) . In a recent study, the high-molecular-weight band was ascribed to the mature, fully glycosylated membrane-anchored protein (35) . Errors concerning uneven gel-loading could be excluded for all Western blot experiments by membrane stripping and reprobing with antiTubulin as internal control (data not shown).
These data suggest impaired N-glycosylation of the I63T isoform resulting in ER retention. This issue was further assessed by subjecting immunoprecipitated cell lysates to digestion with endoglycosidase H. As anticipated, only the lower-molecular-weight band was sensitive to endoglycosidase H digestion in wild-type GPI ceruloplasmin and all other mutated isoforms, whereas the higher molecular weight band corresponding to fully glycosylated GPIceruloplasmin remained endoglycosidase H-resistant (Fig. 3A) .
Functional implication of the mutations on copper incorporation
The effect of the ceruloplasmin mutations I63T, D544E, and R793H on copper incorporation into ceruloplasmin at or beyond the trans-Golgi network was investigated by subjecting transfected HEK293 cell lysates to SDS-PAGE under nonreducing conditions without prior heat denaturation, followed by Western blot analysis. In addition to the band at 132 kDa, which reflects apo-ceruloplasmin, a second band with increased mobility corresponding to holoceruloplasmin was detected (Fig. 3B) . The observed differences in the mobility of apo and holoceruloplasmin probably reflect conformational changes associated with copper incorporation and are consistent with previous data (35) . GPI-linked holo-ceruloplasmin was detected for the isoforms of wild-type and R793H GPI-ceruloplasmin, respectively. However, holoceruloplasmin was not present in the I63T isoform and less prominent in the D544E isoform. In a second experiment, transfected cell lysates were split into two aliquots and subjected to SDS-PAGE with or without prior heating under reducing or nonreducing conditions. The holoceruloplasmin band was abbrogated by heating the cell lysates prior to gel-loading (Fig. 3B) , implying transformation of holo-ceruloplasmin to apo-ceruloplasmin due to loss of copper by heat denaturation.
DISCUSSION
Ceruloplasmin has ferroxidase activity and thus plays an important role in iron metabolism and as an antioxidant. The discovery of heteroallelic ceruloplasmin missense-mutations in PD (33) Page 7 of 20 (page number not for citation purposes) prompted us to investigate the systemic iron metabolism in affected mutation carriers and to characterize these mutations in cell culture.
The mutant I63T ceruloplasmin was found to be retained in the ER due to impaired Nglycosylation even though N-glycosylation sites were not altered by the missense mutation. Thus, transport to the late secretory pathway for copper incorporation in the trans-Golgi network was impeded. The failure to pass the ER quality control may lead to accumulation of misfolded ceruloplasmin, which is eventually subjected to ER-associated degradation (39) due to induction of an "unfolded protein response" with subsequent activation of programmed cell death (40) (Fig. 4B) . Consistent with these findings, ceruloplasmin concentrations with half of the normal control value and markedly reduced ferroxidase activity were found in a heteroallelic PD patient carrying the I63T mutation. In addition, reduced serum iron and transferrin saturation found in this PD patient could reflect decreased iron efflux from iron storage sites to the serum for binding, e.g., to apo-transferrin due to impaired ceruloplasmin ferroxidase activity, as ceruloplasmin was reported to be responsible for iron efflux from different cell types (28, (41) (42) (43) . However, increased serum ferritin levels in response to cellular iron accumulation were not detected in the PD patient reported here carrying the I63T ceruloplasmin mutation. This finding may suggest that the amount of reactive iron was increased in this patient and present in cells in a labile iron pool. In contrast to low serum iron, brain iron might be increased as indicated by SN hyperechogenicity in the PD patient with the I63T mutation. Thus, incomplete functional and expressional compensation by the wild-type ceruloplasmin in the PD patient heterozygous for the I63T ceruloplasmin mutation may lead to slow SN iron accumulation resulting in progressive cell death. Brain iron accumulation was also observed in ceruloplasmin −/− knockout mice and in patients with hereditary aceruloplasminemia due to homozygous loss of function mutations in ceruloplasmin (30, (44) (45) (46) . However, besides some similarities in serum findings, no remarkable signs of damage to visceral organs characteristic for aceruloplasminemia (47) and ceruloplasmin −/− mice (44) were detected in the PD patient carrying the I63T ceruloplasmin mutation. Even so, individuals with hypoceruloplasminemia due to heteroallelic ceruloplasmin mutations either presenting with no or mild neurological symptoms were reported so far (48, 49) , no one of these individuals showed exclusively the clinical phenotype of PD as the PD patient heterozygous for the I63T ceruloplasmin mutation.
In all other PD patients analyzed in this study, carrying either the D544E or R793H substitution or being compound heterozygous for both, ceruloplasmin concentrations were reduced by ~20% independent of the type of the ceruloplasmin missense mutation. A reduction in ferroxidase activity was also observed with the most severe decrease in patients with the D544E and D544E/R793H substitution. These results are consistent with a study reporting significant lower serum ceruloplasmin and a decrease of ceruloplasmin oxidase activity with the duration of the disease in PD patients (50) . Unaltered or increased serum ceruloplasmin levels have also been reported in PD (51, 52) . These patients, however, were not selected regarding their iron load of the SN as measured by transcranial ultrasound in our study.
Ceruloplasmin protein aggregations due to oxidative modifications after incubation with reactive oxygen species (53) may also account for the reduced amount of serum ceruloplasmin and subsequently the reduced ferroxidase activity observed in PD patients. Moreover, oxidatively damaged ceruloplasmin or reactive iron alone, being increased with loss of ceruloplasmin ferroxidase activity, were reported to induce intracellular aggregation of α-synuclein (54-56), the main component of Lewy bodies, which are a pathological hallmark of PD.
However, the significant reduction of 36% in ferroxidase activity in PD patients with the D544E polymorphism, which is similar to the PD patient with D544E/R793H, is much higher than the reduction in PD patients with the R793H substitution of only 13-15%. We thus assume that the ceruloplasmin polymorphism D544E may cause an imbalance in iron metabolism contributing to oxidative stress in PD. Indeed, this polymorphism did not affect ER quality control required for exit from the ER or trafficking to its final cellular or extracellular location (Fig. 4C) . However, although not directly altering copper binding sites, it may alter the native conformation possibly causing an impaired copper incorporation as shown by Western blot analysis (Fig. 3B) . This finding is consistent with previous biochemical studies of other ceruloplasmin mutations (57) and implies expression of apo-ceruloplasmin devoid of enzyme activity (58, 59) . Thus, similar secretion rates of apo-and holo-ceruloplasmin (60) may explain why serum ceruloplasmin levels in patients with the D544E substitution were unchanged compared with PD patients with the R793H exchange whereas ceruloplasmin ferroxidase activity was more affected. Studies on copper-deficient rats suggested enhanced degradation of apo-ceruloplasmin in serum (60) . However, this cannot be deduced from our data. Alternatively, it may indicate increased loss of copper from holo-ceruloplasmin due to conformation instability instead of expression of copperdeficient apo-ceruloplasmin. In addition, the finding that only in normal controls the ferroxidase activity is correlated with iron, ceruloplasmin, and transferrin saturation indicates impaired ferroxidase activity in both PD patients and controls carrying the D544E polymorphism. The functional deficits in these heteroallelic individuals affected by the polymorphism may mainly be compensated by the wild-type allel. However, they may induce the variation instability for ceruloplasmin concentration and ferroxidase activity observed in healthy controls with the D544E polymorphism. Taken together, the D544E polymorphism might act together with further genetic or environmental factors and predispose for iron-induced oxidative stress observed in PD, although the number of patients with this mutation has to be further extended for a definite statement.
Reduction in serum ceruloplasmin concentration and ferroxidase activity in the two patients with the R793H mutation was only marginal. As cell culture experiments did not reveal any abnormalities when compared with wild-type GPI-ceruloplasmin, a decisive role of this missense mutation in iron metabolism imbalances of PD seems unlikely.
The only compound heterozygous PD patient with D544E/R793H showed in addition to reduced ceruloplasmin and ferroxidase levels markedly reduced transferrin levels, whereas in the compound heterozygous control only transferrin levels were reduced. Screening for more individuals affected by both ceruloplasmin missense mutations, and further analysis of these individuals are necessary to assess the importance of these findings.
In summary, we could show functional impairment of iron metabolism in one PD patient carrying the rare I63T ceruloplasmin mutation implicating relevance for iron-induced oxidative stress in PD in this patient. Moreover, we provide evidence that the D544E polymorphism may present a vulnerability factor for oxidative stress in the SN of PD patients, which directly links this mutation to SN iron accumulation in some PD patients and preclinical controls. Therefore, our data strongly support an involvement of ceruloplasmin in iron-induced oxidative stress, which may lead to the clinical phenotype of PD. Wild-type (wt) GPI-ceruloplasmin (Cp) is N-glycosylated in the endoplasmatic reticulum (ER) and Golgi apparatus; after incorporation of 6 copper atoms in the trans-Golgi network (TGN), holo GPI-ceruloplasmin is transported to the cell surface, where it oxidizes toxic iron(II) to iron(III). B) The I63T missense mutation affects N-glycosylation of GPI-linked ceruloplasmin leading to failure of passing ER quality control. ER accumulation of unfolded apo-GPI-Cp I63T activates the "untranslated protein response" (UPR) including 1) translational attenuation; 2) increased folding capacity of the ER; 3) ER-associated protein degradation by the ubiquitin-proteasome pathway; and 4) apoptosis. Absent ferroxidase activity of ceruloplasmin lead to the generation of reactive oxygen species (ROS). C) The D544E missense mutation causes failure of copper incorporation into ceruloplasmin in the trans-Golgi network. Therefore apo-ceruloplasmin with absent ferroxidase activity is transported to the cell surface leading to generation of reactive oxygen species.
